vs
Capitol Federal Financial, Inc.（CFFN）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是Capitol Federal Financial, Inc.的1.2倍（$69.8M vs $56.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 35.7%，领先348.3%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs 21.0%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 36.0%）
国会联邦储蓄银行（CapFed）成立于1893年，是获得联邦特许并承保的储蓄银行，总部位于堪萨斯州托皮卡。该行目前共有51个网点，覆盖堪萨斯城都会区的堪萨斯州与密苏里州两侧，为个人及企业提供各类金融服务，其控股公司国会联邦金融 Inc.在纳斯达克挂牌上市。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
CFFN vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.2倍
$56.8M
营收增速更快
RIGL
高出0.2%
21.0%
净利率更高
RIGL
高出348.3%
35.7%
两年增速更快
RIGL
近两年复合增速
36.0%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $56.8M | $69.8M |
| 净利润 | $20.3M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | 44.4% | 33.2% |
| 净利率 | 35.7% | 384.0% |
| 营收同比 | 21.0% | 21.2% |
| 净利润同比 | 31.6% | 1769.2% |
| 每股收益（稀释后） | $0.16 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CFFNRIGL
| Q4 25 | $56.8M | $69.8M | ||
| Q3 25 | $54.6M | $69.5M | ||
| Q2 25 | $50.7M | $101.7M | ||
| Q1 25 | $48.8M | $53.3M | ||
| Q4 24 | $46.9M | $57.6M | ||
| Q3 24 | — | $55.3M | ||
| Q2 24 | $45.0M | $36.8M | ||
| Q1 24 | $46.0M | $29.5M |
净利润CFFNRIGL
| Q4 25 | $20.3M | $268.1M | ||
| Q3 25 | $18.8M | $27.9M | ||
| Q2 25 | $18.4M | $59.6M | ||
| Q1 25 | $15.4M | $11.4M | ||
| Q4 24 | $15.4M | $14.3M | ||
| Q3 24 | — | $12.4M | ||
| Q2 24 | $9.6M | $-1.0M | ||
| Q1 24 | $13.8M | $-8.2M |
毛利率CFFNRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率CFFNRIGL
| Q4 25 | 44.4% | 33.2% | ||
| Q3 25 | 42.2% | 40.9% | ||
| Q2 25 | 42.6% | 60.1% | ||
| Q1 25 | 39.5% | 23.9% | ||
| Q4 24 | 40.7% | 28.9% | ||
| Q3 24 | — | 25.4% | ||
| Q2 24 | 34.7% | 1.2% | ||
| Q1 24 | 37.5% | -23.6% |
净利率CFFNRIGL
| Q4 25 | 35.7% | 384.0% | ||
| Q3 25 | 34.5% | 40.2% | ||
| Q2 25 | 36.2% | 58.6% | ||
| Q1 25 | 31.6% | 21.5% | ||
| Q4 24 | 32.9% | 24.9% | ||
| Q3 24 | — | 22.5% | ||
| Q2 24 | 21.4% | -2.8% | ||
| Q1 24 | 29.9% | -27.9% |
每股收益（稀释后）CFFNRIGL
| Q4 25 | $0.16 | $14.11 | ||
| Q3 25 | $0.14 | $1.46 | ||
| Q2 25 | $0.14 | $3.28 | ||
| Q1 25 | $0.12 | $0.63 | ||
| Q4 24 | $0.12 | $0.82 | ||
| Q3 24 | — | $0.70 | ||
| Q2 24 | $0.07 | $-0.06 | ||
| Q1 24 | $0.11 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $232.6M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $1.0B | $391.5M |
| 总资产 | $9.8B | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资CFFNRIGL
| Q4 25 | $232.6M | $155.0M | ||
| Q3 25 | $252.4M | $137.1M | ||
| Q2 25 | $175.0M | $108.4M | ||
| Q1 25 | $340.4M | $77.1M | ||
| Q4 24 | $170.3M | $77.3M | ||
| Q3 24 | — | $61.1M | ||
| Q2 24 | $317.8M | $49.1M | ||
| Q1 24 | $443.5M | $49.5M |
总债务CFFNRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益CFFNRIGL
| Q4 25 | $1.0B | $391.5M | ||
| Q3 25 | $1.0B | $117.6M | ||
| Q2 25 | $1.0B | $81.9M | ||
| Q1 25 | $1.0B | $18.6M | ||
| Q4 24 | $1.0B | $3.3M | ||
| Q3 24 | — | $-14.6M | ||
| Q2 24 | $1.0B | $-29.9M | ||
| Q1 24 | $1.0B | $-31.7M |
总资产CFFNRIGL
| Q4 25 | $9.8B | $513.6M | ||
| Q3 25 | $9.8B | $242.5M | ||
| Q2 25 | $9.7B | $206.7M | ||
| Q1 25 | $9.7B | $176.0M | ||
| Q4 24 | $9.5B | $164.0M | ||
| Q3 24 | — | $139.4M | ||
| Q2 24 | $9.6B | $128.4M | ||
| Q1 24 | $9.7B | $126.5M |
负债/权益比CFFNRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $17.4M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $15.8M | — |
| 自由现金流率自由现金流/营收 | 27.9% | — |
| 资本支出强度资本支出/营收 | 2.8% | — |
| 现金转化率经营现金流/净利润 | 0.86× | 0.08× |
| 过去12个月自由现金流最近4个季度 | $91.2M | — |
8季度趋势，按日历期对齐
经营现金流CFFNRIGL
| Q4 25 | $17.4M | $22.0M | ||
| Q3 25 | $55.0M | $24.0M | ||
| Q2 25 | $12.4M | $30.5M | ||
| Q1 25 | $15.5M | $-893.0K | ||
| Q4 24 | $5.6M | $14.5M | ||
| Q3 24 | — | $21.7M | ||
| Q2 24 | $19.1M | $302.0K | ||
| Q1 24 | $20.5M | $-5.0M |
自由现金流CFFNRIGL
| Q4 25 | $15.8M | — | ||
| Q3 25 | $49.8M | — | ||
| Q2 25 | $10.8M | — | ||
| Q1 25 | $14.7M | — | ||
| Q4 24 | $4.5M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $16.4M | — | ||
| Q1 24 | $19.0M | — |
自由现金流率CFFNRIGL
| Q4 25 | 27.9% | — | ||
| Q3 25 | 91.3% | — | ||
| Q2 25 | 21.2% | — | ||
| Q1 25 | 30.2% | — | ||
| Q4 24 | 9.5% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 36.5% | — | ||
| Q1 24 | 41.4% | — |
资本支出强度CFFNRIGL
| Q4 25 | 2.8% | — | ||
| Q3 25 | 9.5% | — | ||
| Q2 25 | 3.2% | — | ||
| Q1 25 | 1.5% | — | ||
| Q4 24 | 2.5% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 5.9% | — | ||
| Q1 24 | 3.2% | — |
现金转化率CFFNRIGL
| Q4 25 | 0.86× | 0.08× | ||
| Q3 25 | 2.93× | 0.86× | ||
| Q2 25 | 0.67× | 0.51× | ||
| Q1 25 | 1.01× | -0.08× | ||
| Q4 24 | 0.36× | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | 1.98× | — | ||
| Q1 24 | 1.49× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
